Webinar :Register now for webinar on 'Trade BankNifty in just 15 minutes a day'
Last Updated : Oct 14, 2019 04:12 PM IST | Source: Moneycontrol.com

Ipca Labs Q2 PAT seen up 34% YoY to Rs. 160.2 cr: Emkay

Net Sales are expected to increase by 12.8 percent Y-o-Y (up 11.3 percent Q-o-Q) to Rs. 1,125.4 crore, according to Emkay.

Representative image
Representative image
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Emkay has come out with its second quarter (July-September’ 19) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Ipca Labs to report net profit at Rs. 160.2 crore up 34% year-on-year (up 21% quarter-on-quarter).


Net Sales are expected to increase by 12.8 percent Y-o-Y (up 11.3 percent Q-o-Q) to Rs. 1,125.4 crore, according to Emkay.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 34 percent Y-o-Y (up 18 percent Q-o-Q) to Rs. 230.7 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

First Published on Oct 14, 2019 04:12 pm
Sections